Want to see HK:8158 full AI Analyst Report?
Total Valuation
China Regenerative Medicine International Limited has a market cap or net worth of HK$65.72M. The enterprise value is HK$170.92.
Market CapHK$65.72M
Enterprise ValueHK$170.92
Share Statistics
China Regenerative Medicine International Limited has 304,252,470 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding304,252,470
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
China Regenerative Medicine International Limited’s return on equity (ROE) is 0.51 and return on invested capital (ROIC) is -0.29%.
Return on Equity (ROE)0.51
Return on Assets (ROA)0.16
Return on Invested Capital (ROIC)-0.29%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee2.40M
Profits Per Employee917.50K
Employee Count30
Asset Turnover0.43
Inventory Turnover14.82
Valuation Ratios
The current PE Ratio of China Regenerative Medicine International Limited is 2.4. China Regenerative Medicine International Limited’s PEG ratio is 0.08.
PE Ratio2.4
PS Ratio1.77
PB Ratio2.39
Price to Fair Value2.39
Price to FCF31.74
Price to Operating Cash Flow16.42
PEG Ratio0.08
Income Statement
In the last 12 months, China Regenerative Medicine International Limited had revenue of 72.06M and earned 27.52M in profits. Earnings per share was 0.09.
Revenue72.06M
Gross Profit41.92M
Operating Income-1.59M
Pretax Income15.19M
Net Income27.52M
EBITDA8.26M
Earnings Per Share (EPS)0.09
Cash Flow
In the last 12 months, operating cash flow was 4.09M and capital expenditures -70.00K, giving a free cash flow of 4.03M billion.
Operating Cash Flow4.09M
Free Cash Flow4.03M
Free Cash Flow per Share0.01
Dividends & Yields
China Regenerative Medicine International Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.05
52-Week Price Change-74.30%
50-Day Moving Average0.27
200-Day Moving Average0.37
Relative Strength Index (RSI)38.21
Average Volume (3m)55.39K
Important Dates
China Regenerative Medicine International Limited upcoming earnings date is Apr 1, 2027, TBA (Not Confirmed).
Last Earnings DateAug 21, 2026
Next Earnings DateApr 1, 2027
Ex-Dividend Date―
Financial Position
China Regenerative Medicine International Limited as a current ratio of 1.14, with Debt / Equity ratio of 95.95%
Current Ratio1.14
Quick Ratio1.12
Debt to Market Cap0.24
Net Debt to EBITDA5.22
Interest Coverage Ratio-1.32
Taxes
In the past 12 months, China Regenerative Medicine International Limited has paid 12.34M in taxes.
Income Tax12.34M
Effective Tax Rate0.81
Enterprise Valuation
China Regenerative Medicine International Limited EV to EBITDA ratio is 20.68, with an EV/FCF ratio of 42.46.
EV to Sales2.37
EV to EBITDA20.68
EV to Free Cash Flow42.46
EV to Operating Cash Flow41.73
Balance Sheet
China Regenerative Medicine International Limited has HK$8.17M in cash and marketable securities with HK$51.31M in debt, giving a net cash position of -HK$43.14M billion.
Cash & Marketable SecuritiesHK$8.17M
Total DebtHK$51.31M
Net Cash-HK$43.14M
Net Cash Per Share-HK$0.14
Tangible Book Value Per ShareHK$0.18
Margins
Gross margin is 58.17%, with operating margin of -2.21%, and net profit margin of 38.20%.
Gross Margin58.17%
Operating Margin-2.21%
Pretax Margin21.08%
Net Profit Margin38.20%
EBITDA Margin11.47%
EBIT Margin-2.21%
Analyst Forecast
The average price target for China Regenerative Medicine International Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-20.48%
EPS Growth Forecast54.97%